Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
Korean Journal of Radiology
;
: 175-178, 2008.
Artigo
em Inglês
| WPRIM
| ID: wpr-82034
ABSTRACT
Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Biópsia
/
Refluxo Gastroesofágico
/
Tomografia Computadorizada por Raios X
/
Doenças Pulmonares Intersticiais
/
Cirurgia Torácica Vídeoassistida
/
2-Piridinilmetilsulfinilbenzimidazóis
/
Pulmão
/
Antiulcerosos
Limite:
Idoso
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Korean Journal of Radiology
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS